Atena Equity Partners completed the acquisition of Sidefarma.

Atena Equity Partners, a private equity firm, completed the acquisition of Sidefarma, a pharmaceutical company. Financial terms were not disclosed. "The health area is experiencing increasing global demand and Sidefarma is a company with strong potential that allows us to explore this trend. With its manufacturing and technological skills, the company can take advantage of the sustained growth of the pharmaceutical sector, both nationally and internationally". And he reveals: "The strategy provides for the enhancement of installed capacity, the strengthening of the management team, the continuous improvement of processes and the dynamization of commercial activity," Miguel Lancastre, Athena Equity Partners Founding Partner.